Diclofenac plasma protein binding: PK-PD modelling in cardiac patients submitted to cardiopulmonary bypass

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 3, 1997, Pages 369-374

  Auler Jr , J O ^a   Espada, E B ^a   Crivelli, E ^a   Quintavalle, T B G ^a   Kurata, A ^a   Stolf, N A G ^a   Issy, A M ^a   Paschoa, O E D ^b   Danhof, M ^b   Breimer, D D ^b   Chamone, D A F ^a   Santos, S R C J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

analgesia; cardiopulmonary bypass; diclofenac; kinetic dynamic parameters; plasma protein binding; visual analogue scale

Indexed keywords

DICLOFENAC;

ADULT; AGED; ANALGESIA; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PHARMACODYNAMICS; POSTOPERATIVE PAIN;

SIGMOIDEA;

EID: 8244222295     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-879x1997000300010     Document Type: Article

References (14)

1. Raja SN, Meyer RA & Campbell JN (1988). Peripheral mechanisms of somatic pain. Anesthesiology, 68: 571-590.
2. Degen PH, Dieterle W, Schneider W, Theobald W & Sinterhauf U (1988). Pharmacokinetics of dictofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients. Xenobiotica, 18: 1449-1455.
3. Riess W, Stierlin H, Degen P, Faigle JW, Gérardin A, Moppert J, Sallmann A, Schmid K, Schweizer A, Sule M, Theobald W & Wagner J (1978). Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scandinavian Journal of Rheumatology, 22 (Suppl): 17-29.
4. Holley FO, Ponganis KV & Stansky DR (1982). Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clinical Pharmacokinetics, 7: 234-251.
5. Menassé R, Hendwall J, Kraetz J, Pericin L, Riesterer L, Sallmann A, Ziel R & Jaques R (1978). Pharmacological properties of diclofenac sodium and its metabolites. Scandinavian Journal of Rheumatology, 22 (Suppl): 5-16.
6. Lanchote VL, Donzella H, Chamone DAF & Santos SRCJ (1996). A simplified assay using high-performance liquid chromatography for the simultaneous determination of antipyrine and its three major metabolites in urine: a drug metabolism study. Revista de Farmácia e Bioquimica, 32 (in press).
7. Scott J & Huskisson EC (1976). Graphic representation of pain. Pain, 2: 176-184.
8. Rosenkranz H, Schlossmann K & Scholtan W (1974). Die Bindung von 4-(2′-nitrophenyl-1,4-dihydropyridin-3,5-dicarbon-säuredimethylester (Nifedipine) sowie von anderen koronarwirksamen Stoffen an die Eiweißkörper des Serums. Arzneimittelforschung, 24: 455-466.
9. Santos SRCJ, Donzella H, Bertoline MA, Pereira MD, Omosako CEK & Porta V (1992). Simplified micromethod for the HPLC measurement of diclofenac in plasma. Brazilian Journal of Medical and Biological Research, 25: 125-128.
10. Santos SRCJ (1982). Nova técnica analitica para estudo farmacocinético da nifedipina. Doctoral thesis, USP, Sāo Paulo.
11. Ritschel WA (1986). Handbook of Pharmacokinetics. 3rd edn. Drug Intelligence Publications, Bethesda.
12. Holford NHG & Sheiner LB (1981). Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics, 6: 429-453.
13. Shargel L & Yu ABC (1991). Applied Biopharmaceutics and Pharmacokinetics. 3rd edn. Prentice-Hall International, London, 465-491.
14. Sachs L (1984). Applied Statistics. 2nd edn. Springer, New York.